日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of substituted 2-(4-(sulfonyl)piperazin-1-yl)quinazoline molecular hybrids as a new class of antimalarials

开发取代的2-(4-(磺酰基)哌嗪-1-基)喹唑啉分子杂合物作为一类新型抗疟药

Madhav, Hari; Panda, Ashutosh; Datta, Dipanwita; Shaheen, Kashfa; Rahman, Abdur; Khan, Azhar Tariq; Bhattacharjee, Souvik; Kumar, Dhiraj; Malhotra, Pawan; Hoda, Nasimul

Making prescriptions "talk" to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study)

让处方“与中风和心脏病患者对话”以提高用药依从性:一项随机临床试验的结果(会说话的处方研究)

Kamal, Ayeesha Kamran; Khalid, Wardah; Muqeet, Abdul; Jamil, Anum; Farhat, Kashfa; Gillani, Sehar Rahim Ali; Zulfiqar, Maryam; Saif, Mehreen; Muhammad, Aliya Amin; Zaidi, Fabiha; Mustafa, Mohammad; Gowani, Ambreen; Sharif, Shahrukh; Bokhari, Syedah Saira; Tai, Javed; Rahman, Nasir; Sultan, Fateh Ali Tipoo; Sayani, Saleem; Virani, Salim S

Using a tailored health information technology- driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx) - study protocol for a randomized controlled trial

利用定制化的健康信息技术驱动干预措施(Talking Rx)提高巴基斯坦血管疾病患者的健康素养和药物依从性——一项随机对照试验的研究方案

Kamal, Ayeesha Kamran; Muqeet, Abdul; Farhat, Kashfa; Khalid, Wardah; Jamil, Anum; Gowani, Ambreen; Muhammad, Aliya Amin; Zaidi, Fabiha; Khan, Danyal; Elahi, Touseef; Sharif, Shahrukh; Raz, Sibtain; Zafar, Taha; Bokhari, Syedah Saira; Rahman, Nasir; Sultan, Fateh Ali Tipoo; Sayani, Saleem; Virani, Salim S